有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | [2-[(4-Chlorophenyl)methylamino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C17H14ClF2NO3S |
|
—— | [(2R)-1-(cyclohexylmethylamino)-1-oxopropan-2-yl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C18H23F2NO3S |
|
—— | (2R)-2-[(4-benzyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N,N-dimethylpropanamide | —— | C18H20N4OS2 |
|
—— | [2-[[(2R)-2-cyano-3-methylbutan-2-yl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C16H18F2N2O3S |
|
—— | [(2R)-1-[2-(4-fluorophenyl)ethylamino]-1-oxopropan-2-yl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C19H18F3NO3S |
|
—— | [2-(2-Cyanoethylamino)-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C13H12F2N2O3S |
|
—— | [2-[2-(4-Fluorophenyl)ethylamino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C18H16F3NO3S |
|
—— | [(3S)-3-cyano-3-(4-methyl-1,3-thiazol-2-yl)-2-oxopropyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C16H12F2N2O3S2 |
|
—— | (2-Amino-2-oxoethyl) 2-(2,5-difluorophenyl)sulfanylacetate | —— | C10H9F2NO3S |
|
—— | [2-(2-Acetylhydrazinyl)-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C12H12F2N2O4S |
|
—— | [2-oxo-2-[[(2R)-4-phenylbutan-2-yl]amino]ethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C20H21F2NO3S |
|
—— | [2-[(1-Cyanocyclopentyl)amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C16H16F2N2O3S |
|
—— | [(2R)-1-[[(1S,2R)-2-methylcyclohexyl]amino]-1-oxopropan-2-yl] 2-(2,5-difluorophenyl)sulfanylacetate | —— | C18H23F2NO3S |
|
—— | (2R)-2-[(4-amino-6-methyl-5-oxo-1,2,4-triazin-3-yl)sulfanyl]-N-ethylpropanamide | —— | C9H15N5O2S |
|
—— | N-[2-(2-fluorophenyl)ethyl]-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C20H28FN5O2S |
|
—— | [2-[2-(4-bromophenyl)sulfanylethylamino]-2-oxoethyl] 2-[(1S)-cyclopent-2-en-1-yl]acetate | —— | C17H20BrNO3S |
|
—— | (2S)-2-[(4-amino-5-tert-butyl-1,2,4-triazol-3-yl)sulfanyl]-N-ethylpropanamide | —— | C11H21N5OS |
|
—— | N-cyclopropyl-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylsulfanyl)acetamide | —— | C16H24N4O3S2 |
|
—— | 4-[4-(2-Methylpropyl)-5-[(5-phenyl-1,2-oxazol-3-yl)methylsulfanyl]-1,2,4-triazol-3-yl]morpholine | —— | C20H25N5O2S |
|
—— | (2R)-N-ethyl-2-[[4-(2-phenylethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C20H24N4OS2 |
|
—— | 3-cyclopropyl-5-[(1R)-1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]ethyl]sulfanyl-1,2,4-triazol-4-amine | —— | C16H18N6OS |
|
—— | N-[(1S)-1-cyclopropylethyl]-2-[[5-[2-[[(1S)-1-cyclopropylethyl]amino]-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C16H24N4O2S3 |
|
—— | 2-[[4-amino-5-[(4-fluorophenyl)methyl]-1,2,4-triazol-3-yl]sulfanyl]-N-[(2-methylphenyl)methyl]acetamide | —— | C19H20FN5OS |
|
—— | 2-[[5-(3-chloroanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(1S)-1-(furan-2-yl)ethyl]acetamide | —— | C16H15ClN4O2S2 |
|
—— | [2-[2-(2-methylphenyl)ethylamino]-2-oxoethyl] (2S)-2-(4-methylphenyl)sulfanylpropanoate | —— | C21H25NO3S |
|
—— | 2-[[4-amino-5-[(4-fluorophenyl)methyl]-1,2,4-triazol-3-yl]sulfanyl]-N-[2-(2-methylphenyl)ethyl]acetamide | —— | C20H22FN5OS |
|
—— | N-cyclopropyl-2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(2-fluorophenyl)methyl]acetamide | —— | C20H26FN5O2S |
|
—— | N-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H24N4O3S |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C19H27N5O2S |
|
—— | 2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[2-(2-methylphenyl)ethyl]acetamide | —— | C19H27N5O2S |
|
—— | N-[(1S)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H24N4O3S |
|
—— | N-[2-(3-chlorophenyl)ethyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C13H15ClN4OS |
|
—— | 2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-methyl-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C17H25N5O2S2 |
|
—— | 5-[(3-chlorophenyl)methylsulfanyl]-N-methyl-1,3,4-thiadiazol-2-amine | —— | C10H10ClN3S2 |
|
—— | 2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[2-(2-fluorophenyl)ethyl]acetamide | —— | C18H24FN5O2S |
|
—— | 5-methyl-7-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanyl]-[1,2,4]triazolo[1,5-a]pyrimidine | —— | C9H9N7S |
|
—— | N-(2-cyanoethyl)-N-(furan-2-ylmethyl)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C13H15N5O2S |
|
—— | 3-[(4-Methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole | —— | C13H12N4OS |
|
—— | 5-[(2-fluorophenyl)methylsulfanyl]-N-methyl-1,3,4-thiadiazol-2-amine | —— | C10H10FN3S2 |
|
—— | (2S)-2-[[5-(methylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]cyclohexan-1-one | —— | C9H13N3OS2 |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C19H27N5O2S |
|
—— | 4-[4-benzyl-5-[(1S)-1-(2-chlorophenyl)ethyl]sulfanyl-1,2,4-triazol-3-yl]morpholine | —— | C21H23ClN4OS |
|
—— | (2S)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-propan-2-ylpropanamide | —— | C19H27N5O2S |
|
—— | 4-[4-Benzyl-5-[(2-chlorophenyl)methylsulfanyl]-1,2,4-triazol-3-yl]morpholine | —— | C20H21ClN4OS |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(2R)-butan-2-yl]acetamide | —— | C19H27N5O2S |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S,2S)-2-methylcyclohexyl]acetamide | —— | C22H31N5O2S |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-(2-cyanoethyl)acetamide | —— | C18H22N6O2S |
|
—— | 4-[4-Benzyl-5-[(2,5-dimethylphenyl)methylsulfanyl]-1,2,4-triazol-3-yl]morpholine | —— | C22H26N4OS |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-propan-2-ylacetamide | —— | C18H25N5O2S |
|
—— | 4-[4-Benzyl-5-[(4-methylsulfanylphenyl)methylsulfanyl]-1,2,4-triazol-3-yl]morpholine | —— | C21H24N4OS2 |
|